Intrauterine use of granulocyte colony-stimulating factor in patients with thin endometrium in frozen embryo transfer programs
- Authors: Dzhincharadze L.G.1, Abubakirov A.N.1, Mishieva N.G.1
-
Affiliations:
- Academician V.I. Kulakov National Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- Issue: No 8 (2020)
- Pages: 106-110
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248916
- DOI: https://doi.org/10.18565/aig.2020.8.106-110
- ID: 248916
Cite item
Open Access
Access granted
Abstract
Objective. To determine the efficacy of intrauterine use of granulocyte colony-stimulating factor (G-CSF) for the increase of endometrial thickness and pregnancy rates in patients with thin endometrium in frozen embryo transfer programs. Materials and methods. The main group included 15 patients with thin endometrium, which was refractory to standard methods of treatment; embryo transfer cycles were cancelled several times due to insufficient endometrial thickness in these patients. In addition to hormone replacement therapy (HRT), the patients were given an intrauterine injection of G-CSF on the 5-6th and 12-13th days of the menstrual cycle. The control group included 17 patients with thin endometrium, they received only HRT. The endometrial thickness was measured by ultrasound on the 14-15th and 20-21st (the day of embryo transfer) days of the menstrual cycle. The primary outcome was an increase in endometrial thickness greater than 7 mm on the day of embryo transfer, the secondary outcome was pregnancy rate. Results. Endometrial thickness greater than 7mm was observed in 7 patients (46.67%) in G-CSF group, and in 8 (47.06%) patients in the control group; the difference was not statistically significant (p=0.983). The average increase in endometrial thickness compared to the previous cycle was 0.6 mm. The average thickness of the endometrium was 7.32 mm in the main group. Embryo transfer was performed in 8 (53.33%) patients in G-CSF group, pregnancy occurred in 4 (50%) patients, clinical pregnancy in 3 (37.5%) patients, one patient had a biochemical pregnancy. At the time of the article’s publication there were two (25%) livebirths and one ongoing pregnancy. In the control group, the average thickness of the endometrium was 6.9 mm. Embryo transfer was performed in 4 patients (23.53%). But no pregnancy was achieved in any of the patients, the difference was not statistically significant (p=0.84). Conclusion. Despite the results that were not statistically significant, patients in G-CSF group showed a tendency for the increase in endometrial thickness and pregnancy rates, as well as the decrease in embryo transfer cycle cancellations. It is worth conducting studies with a larger sample of patients to obtain more reliable results.
Full Text
About the authors
Lana G. Dzhincharadze
Academician V.I. Kulakov National Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: lanachka@list.ru
graduate student of 1st Gynecology department
Aydar N. Abubakirov
Academician V.I. Kulakov National Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: nondoc555@yahoo.com
PhD, Head of 1st Gynecology department
Nona G. Mishieva
Academician V.I. Kulakov National Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: nondoc555@mail.ru
PhD, Senior researcher of 1st Gynecology department
References
- Khalifa G., Brzyski R.G., Oehninger S., Acosta AA, Muasher SJ. Sonographic appearance of the endometrium: the predictive value for the outcome of in vitro fertilization in stimulated cycles. Hum. Reprod. 1992; 7(5): 677-80. https:// dx.doi.org/10.1093/oxfordjournals.humrep.a137718.
- Zhang X., Chen C.H., Confino E., Barnes R., Milad M., Kazer R.R. Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer. Fertil. Steril. 2005; 83(2): 336-40. https://dx.doi.org/10.1016/j.fertnstert.2004.09.020.
- Абдурахманова Н.Ф., Гвоздева А.Д., Зиганшина М.М., Долгушина Н.В. Результаты программ вспомогательных репродуктивных технологий у пациенток с «тонким» эндометрием. Гинекология. 2019; 21(1): 23-7. [Abdurakhmanova N.F., Gvozdeva A.D., Ziganshina M.M., Dolgushina N.V. The results of assisted reproductive technology programs in patients with “thin" endometrium. Gynecology. 2019; 21(1): 23-7. (in Russian)]. https://dx.doi.org/ 10.26442/20795696.2019.1.190232.
- Kasius A., Smit J.G., Torrance H.L., Eijkemans M.J., Mol B.W., Opmeer B.C., Broekmans FJ. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Hum. Reprod. Update. 2014; 20(4): 530-41. https://dx.doi.org/10.1093/humupd/dmu011.
- Боярский К.Ю., Гайдуков С.Н., Пальченко Н.А. Современный взгляд на проблему рецептивности и тонкого эндометрия в программах ВРТ (обзор литературы). Проблемы репродукции. 2013; 19(4): 51-60. [Boyarsky K.Yu., Gaidukov S.N., Palchenko N.A. Modern view on the problem of receptivity and thin endometrium in assisted reproductive technology programs (literature review). Problems of reproduction. 2013; 19(4): 51-60. (in Russian)].
- Корсак В.С., Каменецкий Б.А., Михайлов А.В. Значимость толщины и ультразвуковой структуры эндометрия в программе ЭКО. Проблемы репродукции 2001; 7(3): 36-9. [Korsak V.S., Kamenetsky B.A., Mikhailov A.V. Significance of endometrial thickness and ultrasound structure in the IVF program. Problems of reproduction 2001; 7(3): 36-9. (in Russian)].
- Sher G, Fisch J.D. Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum. Reprod. 2000; 15(4): 806-9. https://dx.doi. org/10.1093/humrep/15.4.806.
- Gleicher N, Vidali A., Bar ad D.H. Successful treatment of unresponsive thin endometrium. Fertil. Steril. 2011; 95(6): 2123. e13-7. https://dx.doi.org/10.1016/j.fertnstert.2011.01.143.
- Barash A., Dekel N., Fieldust S., Segal I., Schechtman E., Granot I. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil. Steril. 2003; 79(6): 1317-22. https:// dx.doi.org/10.1016/s0015-0282(03)00345-5.
- Thomas J., Liu F., Link D.C. Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor. Curr. Opin. Hematol. 2002; 9(3): 183-9. https://dx.doi.org/10.1097/00062752-200205000-00002.
- Dale D.C., Cottle T.E., Fier C.J., Bolyard A.A., Bonilla M.A., Boxer L.A. et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am. J. Hematol. 2003; 72(2): 82-93. https://dx.doi.org/10.1002/ajh.10255.
- Gomez R.C., Pinto M.A., Gonzalez B.M. Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropenia. Clin. Transl. Oncol 2006; 8(10): 729-34. https://dx.doi. org/10.1007/s12094-006-0119-4.
- Gleicher N., Kim A., Michaeli T., Lee H.-J., Shohat-Tal A., Lazzaroni E., Barad D.H. A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. Hum. Reprod. 2013; 28(1):172-7. https://dx.doi.org/10.1093/humrep/des370.
- Kunicki M., Lukaszuk K., Liss J., Skowronska P., Szczyptanska J. Granulocyte colony stimulating factor treatment of resistant thin endometrium in women with frozen-thawed blastocyst transfer. Syst. Biol. Reprod. Med. 2016; 63(1): 49-57. https://dx.doi.org/10.1080/19396368.2016.1251505.
- Bin X., Qiong Z., Jie H., Dabao X., Yanping L. Two protocols to treat thin endometrium with granulocyte colony-stimulating factor during frozen embryo transfer cycles. Reprod. Biomed. Online. 2015; 30(4): 349-58. https://dx.doi. org/10.1016/j.rbmo.2014.12.006.
- Barad D.H., Yu Y., Kushnir V.A., Shohat-Tal A., Lazzaroni E., Lee H.J., Gleicher N. A randomized clinical trial of endometrial perfusion with granulocyte colony-stimulating factor in in vitro fertilization cycles:impact on endometrial thickness and clinical pregnancy rates. Fertil. Steril. 2014; 101(3): 710-5. https:// dx.doi.org/10.1016/j.fertnstert.2013.12.016.
- Tehraninejad E., Tanha F.D., Asadi E., Kamali K., Aziminikoo E., Rezayof E. G-CSF intrauterine for thin endometrium, and pregnancy outcome. J. Family Reprod. Health. 2015; 9(3):107-12.
- Li Yu, Pan P., Chen X., Li Lin, Li Yi, Yang D. Granulocyte colony-stimulating factor administration for infertile women with thin endometrium in frozen embryo transfer program. Reprod. Sci. 2014; 21(3): 381-5. https://dx.doi. org/10.1177/1933719113497286.
- Eftekhar M., Sayadi M., Arabjahvani F. Transvaginal perfusion of G-CSF for infertile women with thin endometrium in frozen ET program: A nonrandomized clinical trial. Iran. J. Reprod. Med. 2014; 12(10): 661-6.
- Mishra V.V., Choudhary S., Sharma U., Aggarwal R., Agarwal R., Gandhi K., Goraniya N. Effects of granulocyte colony-stimulating factor (GCSF) on persistent thin endometrium in frozen embryo transfer (FET) cycles. J. Obstet. Gynecol. India. 2016; 66(Suppl.1): S407-11.
Supplementary files
